{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:20:10Z","timestamp":1770236410562,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sociedade Portuguesa de Reumatologia","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The vasculitides are a group of rare diseases with different manifestations and outcomes. New therapeutic options have led to the need for long-term registries. The Rheumatic Diseases Portuguese Register, Reuma.pt, is a web-based electronic clinical record, created in 2008, which currently includes specific modules for 12 diseases and\u2009&gt;\u200920,000 patients registered from 79 rheumatology centres. On October 2014, a dedicated module for vasculitis was created as part of the European Vasculitis Society collaborative network, enabling prospective collection and central storage of encrypted data from patients with this condition. All Portuguese rheumatology centres were invited to participate. Data regarding demographics, diagnosis, classification criteria, assessment tools, and treatment were collected. We aim to describe the structure of Reuma.pt\/vasculitis and characterize the patients registered since its development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 687 patients, with 1945 visits, from 13 centres were registered; mean age was 53.4\u2009\u00b1\u200919.3\u2009years at last visit and 68.7% were females. The most common diagnoses were Beh\u00e7et\u2019s disease (BD) (42.5%) and giant cell arteritis (GCA) (17.8%). Patients with BD met the International Study Group criteria and the International Criteria for BD in 85.3 and 97.2% of cases, respectively. Within the most common small- and medium-vessel vasculitides registered, median [interquartile range] Birmingham Vasculitis Activity Score (BVAS) at first visit was highest in patients with ANCA-associated vasculitis (AAV) (17.0 [12.0]); there were no differences in the proportion of patients with AAV or polyarteritis nodosa who relapsed (BVAS\u22651) or had a major relapse (\u22651 major BVAS item) during prospective assessment (<jats:italic>p<\/jats:italic>\u2009=\u20091.00,<jats:italic>p<\/jats:italic>\u2009=\u20090.479). Biologic treatment was prescribed in 0.8% of patients with GCA, 26.7% of patients with AAV, and 7.6% of patients with BD. There were 34 (4.9%) deaths reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Reuma.pt\/vasculitis is a bespoke web-based registry adapted for routine care of patients with this form of rare and complex diseases, allowing an efficient data-repository at a national level with the potential to link with other international databases. It facilitates research, trials recruitment, service planning and benchmarking.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-020-01381-0","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T19:03:07Z","timestamp":1588705387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Reuma.pt\/vasculitis \u2013 the Portuguese vasculitis registry"],"prefix":"10.1186","volume":"15","author":[{"given":"Cristina","family":"Ponte","sequence":"first","affiliation":[]},{"given":"Nikita","family":"Khmelinskii","sequence":"additional","affiliation":[]},{"given":"V\u00edtor","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Karine","family":"Luz","sequence":"additional","affiliation":[]},{"given":"Daniela","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Mar\u00edlia","family":"Rodrigues","sequence":"additional","affiliation":[]},{"given":"Mariana","family":"Lu\u00eds","sequence":"additional","affiliation":[]},{"given":"L\u00eddia","family":"Teixeira","sequence":"additional","affiliation":[]},{"given":"Sandra","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Nathalie","family":"Madeira","sequence":"additional","affiliation":[]},{"given":"Joana A.","family":"Aleixo","sequence":"additional","affiliation":[]},{"given":"Teresa","family":"Pedrosa","sequence":"additional","affiliation":[]},{"given":"Sofia","family":"Serra","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Campanilho-Marques","sequence":"additional","affiliation":[]},{"given":"Walter","family":"Castel\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Cordeiro","sequence":"additional","affiliation":[]},{"given":"S\u00edlvia","family":"Fernandes","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Macieira","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Madureira","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Malcata","sequence":"additional","affiliation":[]},{"given":"Romana","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Gra\u00e7a","family":"Sequeira","sequence":"additional","affiliation":[]},{"given":"Jaime C.","family":"Branco","sequence":"additional","affiliation":[]},{"given":"L\u00facia","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Vaz","family":"Patto","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Canas","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 A.","family":"Pereira da Silva","sequence":"additional","affiliation":[]},{"given":"Carmo","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Helena","family":"Canh\u00e3o","sequence":"additional","affiliation":[]},{"given":"Maria J.","family":"Santos","sequence":"additional","affiliation":[]},{"given":"Raashid A.","family":"Luqmani","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o E.","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"1381_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.autrev.2008.07.001","volume":"8","author":"A Miller","year":"2008","unstructured":"Miller A, Basu N, Luqmani RA. Assessment of systemic vasculitis. Autoimmun Rev. 2008;8:170\u20135.","journal-title":"Autoimmun Rev"},{"key":"1381_CR2","first-page":"S118","volume":"32","author":"C Ponte","year":"2014","unstructured":"Ponte C, Sznajd J, O'Neill L, Luqmani RA. Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol. 2014;32:S118\u201325.","journal-title":"Clin Exp Rheumatol"},{"key":"1381_CR3","first-page":"45","volume":"36","author":"H Canh\u00e3o","year":"2011","unstructured":"Canh\u00e3o H, Faustino A, Martins F, Fonseca JE. Rheumatic diseases Portuguese register board coordination, Portuguese Society of Rheumatology. Reuma.Pt - the rheumatic diseases Portuguese register. Acta Reumatol Port. 2011;36:45\u201356.","journal-title":"Acta Reumatol Port"},{"key":"1381_CR4","first-page":"232","volume":"42","author":"MJ Santos","year":"2017","unstructured":"Santos MJ, Canh\u00e3o H, Mour\u00e3o AF, Oliveira Ramos F, Ponte C, Duarte C, et al. Reuma.Pt contribution to the knowledge of immune-mediated systemic rheumatic diseases. Acta Reumatol Port. 2017;42:232\u20139.","journal-title":"Acta Reumatol Port"},{"key":"1381_CR5","first-page":"8","volume":"43","author":"MJ Santos","year":"2018","unstructured":"Santos MJ, Canas da Silva J. Reuma.Pt - structure and innovation. Acta Reumatol Port. 2018;43:8\u20139.","journal-title":"Acta Reumatol Port"},{"key":"1381_CR6","doi-asserted-by":"publisher","first-page":"iii20","DOI":"10.1093\/rheumatology\/kex116","volume":"56","author":"RA Luqmani","year":"2017","unstructured":"Luqmani RA, Craven A, Sznajd J, Basu N, Barrett J, Jayne D, et al. The UK & Ireland Vasculitis Registry (UKIVAS): cross-sectional data on the first 2290 patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV). Rheumatology. 2017;56:iii20\u20132.","journal-title":"Rheumatology"},{"key":"1381_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.20452\/pamw.2146","volume":"124","author":"A Padjas","year":"2014","unstructured":"Padjas A, Sznajd J, Szczeklik W, W\u00f3jcik K, Wawrzycka K, Musia\u0142 J. Rare disease registries: an initiative to establish vasculitis registry in Poland. Pol Arch Med Wewn. 2014;124:143\u20134.","journal-title":"Pol Arch Med Wewn"},{"key":"1381_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ekir.2017.09.008","volume":"2","author":"IM Bajema","year":"2017","unstructured":"Bajema IM, Bruijn JA, Casian A, Cid MC, Csernok E, van Daalen E, et al. The EUVAS 2016 meeting report. Kidney Int Rep. 2017;2:1018\u201331.","journal-title":"Kidney Int Rep"},{"key":"1381_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international Chapel Hill consensus conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1\u201311.","journal-title":"Arthritis Rheum"},{"key":"1381_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122\u20138.","journal-title":"Arthritis Rheum"},{"key":"1381_CR11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/art.1780330811","volume":"33","author":"WP Arend","year":"1990","unstructured":"Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33:1129\u201334.","journal-title":"Arthritis Rheum"},{"key":"1381_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/art.1780330805","volume":"33","author":"RW Lightfoot Jr","year":"1990","unstructured":"Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088\u201393.","journal-title":"Arthritis Rheum"},{"key":"1381_CR13","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 1990;33:1101\u20137.","journal-title":"Arthritis Rheum"},{"key":"1381_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094\u2013100.","journal-title":"Arthritis Rheum"},{"key":"1381_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/art.1780330809","volume":"33","author":"JA Mills","year":"1990","unstructured":"Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura. Arthritis Rheum. 1990;33:1114\u201321.","journal-title":"Arthritis Rheum"},{"key":"1381_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","volume":"63","author":"JG Lanham","year":"1984","unstructured":"Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984;63:65\u201381.","journal-title":"Medicine (Baltimore)"},{"key":"1381_CR17","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","volume":"110","author":"JW Newburger","year":"2004","unstructured":"Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation. 2004;110:2747\u201371.","journal-title":"Circulation"},{"key":"1381_CR18","first-page":"1078","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","unstructured":"International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet."},{"key":"1381_CR19","first-page":"S14","volume":"24","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease","year":"2006","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease. Revision of the international criteria for Behcet\u2019s disease (ICBD). Clin Exp Rheumatol. 2006;24:S14\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"1381_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease. The international criteria for Beh\u00e7et's disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28:338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1381_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/ard.2011.150755","volume":"70","author":"S De Vita","year":"2011","unstructured":"De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, et al. Preliminary classification criteria for the cryoglobulinaemic vasculitis. Ann Rheum Dis. 2011;70:1183\u201390.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10157-013-0854-0","volume":"17","author":"A Craven","year":"2013","unstructured":"Craven A, Robson J, Ponte C, Grayson PC, Suppiah R, Judge A, et al. ACR\/EULAR-endorsed study to develop diagnostic and classification criteria for Vasculitis (DCVAS). Clin Exp Nephrol. 2013;17:619\u201321.","journal-title":"Clin Exp Nephrol"},{"key":"1381_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","volume":"75","author":"L Guillevin","year":"1996","unstructured":"Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore). 1996;75:17\u201328.","journal-title":"Medicine (Baltimore)"},{"key":"1381_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","volume":"90","author":"L Guillevin","year":"2011","unstructured":"Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The five factor score revisited: assessment of prog- noses of systemic necrotizing vasculitides based on the French Vasculitis study group (FVSG) cohort. Medicine (Baltimore). 2011;90:19\u201327.","journal-title":"Medicine (Baltimore)"},{"key":"1381_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acr.20433","volume":"63","author":"R Suppiah","year":"2011","unstructured":"Suppiah R, Judge A, Batra R, Flossmann O, Harper L, H\u00f6glund P, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011;63:588\u201396.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1381_CR26","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis activity score (version3). Ann Rheum Dis. 2009;68:1827\u201332.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"AR Exley","year":"1997","unstructured":"Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage COS. Development and initial validation of the Vasculitis damage index (VDI) for the standardised clinical assessment of damage in the systemic Vasculitides. Arthritis Rheum. 1997;40:371\u201380.","journal-title":"Arthritis Rheum"},{"key":"1381_CR28","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69:798\u2013806.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR29","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1136\/annrheumdis-2012-202111","volume":"72","author":"P Dolezalova","year":"2013","unstructured":"Dolezalova P, Price-Kuehne FE, \u00d6zen S, Benseler SM, Cabral DA, Anton J, et al. Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis activity score (PVAS). Ann Rheum Dis. 2013;72:1628\u201333.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"1381_CR30","first-page":"696","volume":"73","author":"P Dolezalova","year":"2014","unstructured":"Dolezalova P, Wilkinson N, Brogan PA, Ant\u00f3n J, Benseler S, Brunner J, et al. Paediatric Vasculitis damage index: a new tool for standardised disease assessment. Ann Rheum Dis. 2014;73(Suppl2):696\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR31","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/rheumatology\/ket445","volume":"53","author":"E Ntatsaki","year":"2014","unstructured":"Ntatsaki E, Carruthers D, Chakravarty K, D'Cruz D, Harper L, Jayne D, et al. BSR and BHPR standards, guidelines and audit working group. BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis. Rheumatology (Oxford). 2014;53:2306\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1381_CR32","doi-asserted-by":"publisher","first-page":"614","DOI":"10.20344\/amp.9875","volume":"31","author":"N Khmelinskii","year":"2018","unstructured":"Khmelinskii N, Seixas I, Ponte C, Fonseca JE, Macieira C. The added value of a Vasculitis Clinic in a tertiary referral hospital. Acta Medica Port. 2018;31:614\u20137.","journal-title":"Acta Medica Port"},{"key":"1381_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2011","unstructured":"Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011;70:488\u201394.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","volume":"74","author":"J Robson","year":"2015","unstructured":"Robson J, Doll H, Suppiah R, Flossmann O, Harper L, H\u00f6glund P, et al. Damage in the ANCA-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials. Ann Rheum Dis. 2015;74:177\u201384.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR35","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3899\/jrheum.110276","volume":"38","author":"PA Merkel","year":"2011","unstructured":"Merkel PA, Aydin SZ, Boers M, Direskeneli H, Herlyn K, Seo P, et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol. 2011;38:1480\u20136.","journal-title":"J Rheumatol"},{"key":"1381_CR36","first-page":"317e28","volume":"377","author":"JH Stone","year":"2017","unstructured":"Stone JH, Tuckwell K, Dimonaco S, Klearman M, Aringer M, Blockmans D, et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med. 2017;377:317e28.","journal-title":"N Engl J Med"},{"issue":"suppl10","key":"1381_CR37","first-page":"773","volume":"66","author":"J Sznajd","year":"2014","unstructured":"Sznajd J, Salama AD, Jayne D, Chaudhry A, Robson M, Rosa J, et al. United Kingdom & Ireland vasculitis registry (UKIVAS): cross- sectional data on the first 1085 patients. Arthritis Rheumatol. 2014;66(suppl10):773.","journal-title":"Arthritis Rheumatol"},{"key":"1381_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, H\u00f6glund P, et al. French Vasculitis study group (FVSG) and the European Vasculitis Society (EUVAS). Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis. 2013;72:1003\u201310.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR39","doi-asserted-by":"publisher","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","volume":"96","author":"R Solans-Laqu\u00e9","year":"2017","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M, Caminal L, Castillo MJ, Mart\u00ednez-Valle F, et al. Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore). 2017;96:e6083. https:\/\/doi.org\/10.1097\/MD.0000000000006083.","journal-title":"Medicine (Baltimore)"},{"key":"1381_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.20452\/pamw.3920","volume":"127","author":"J Musia\u0142","year":"2017","unstructured":"Musia\u0142 J, W\u00f3jcik K. Polish Vasculitis registry: POLVAS. Pol Arch Intern Med. 2017;127:71\u20132.","journal-title":"Pol Arch Intern Med"},{"key":"1381_CR41","unstructured":"Koldingsenes W. [NORVAS, Norwegian vasculitis register and biobank]. Available from: https:\/\/unn.no\/fag-og-forskning\/forskning\/biobank\/norvas-norsk-vaskulittregister-og-biobank-biobank Cited 11 March 2019."},{"issue":"suppl","key":"1381_CR42","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.lpm.2013.02.034","volume":"42","author":"Z Hruskova","year":"2013","unstructured":"Hruskova Z, Jancova E, Lanska V, Svojanovsky J, Klaboch J, Nemec P, et al. Characteristics and outcomes of patients with ANCA-associated vasculitis in the Czech population. Presse Med. 2013;42(suppl):664\u20135.","journal-title":"Presse Med"},{"key":"1381_CR43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10067-017-3835-y","volume":"37","author":"GE Fragoulis","year":"2018","unstructured":"Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study. Clin Rheumatol. 2018;37:737\u201347.","journal-title":"Clin Rheumatol"},{"key":"1381_CR44","unstructured":"European Reference Networks on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune diseases (ERN - RITA). For Mission, goals and objectives. Available from: http:\/\/rita.ern-net.eu\/about-rita\/mission-goals-and-objectives\/ Cited 11 March 2019."},{"key":"1381_CR45","first-page":"79","volume":"4","author":"P de Souza-Ramalho","year":"1991","unstructured":"de Souza-Ramalho P, D'Almeida MF, Freitas JP, Pinto J. Beh\u00e7et's disease in Portugal. Acta Medica Port. 1991;4:79\u201382.","journal-title":"Acta Medica Port"},{"key":"1381_CR46","first-page":"225","volume":"4","author":"Grupo Nacional para o Estudo da Doen\u00e7a de Beh\u00e7et, Jorge Crespo","year":"1997","unstructured":"Grupo Nacional para o Estudo da Doen\u00e7a de Beh\u00e7et, Jorge Crespo. Beh\u00e7et\u2019s disease - a national casuistic. Med Int. 1997;4:225\u201332.","journal-title":"Med Int"},{"key":"1381_CR47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/annrheumdis-2017-212649","volume":"77","author":"C Dejaco","year":"2018","unstructured":"Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636\u201343.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR48","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583\u201394.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR49","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/ard.2008.088351","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2009;68:318\u201323.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR50","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1136\/ard.2007.080432","volume":"67","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR expert committee. EULAR recommendations for the management of Beh\u00e7et disease. Ann Rheum Dis. 2008;67:1656\u201362.","journal-title":"Ann Rheum Dis"},{"key":"1381_CR51","first-page":"1157","volume":"77","author":"JC Robson","year":"2018","unstructured":"Robson JC, Dawson J, Doll H, Cronholm PF, Milman N, Kellom K, et al. Validation of the ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire. Ann Rheum Dis. 2018;77:1157\u201364.","journal-title":"Ann Rheum Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01381-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T09:08:33Z","timestamp":1722848913000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01381-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1381"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01381-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"21 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The database information security was approved by the Portuguese National Commission for Data Protection and the ethics committees of the participating institutions. All participating patients were asked to sign an inform consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}